An exclusive tool to prevent cancer and papillomavirus injury

INT is the only public structure in Italy with a platform able to automatically process Pap-test samples, detecting in a few hours if Papillomavirus is present and if the infection can turn into cancer.
“It’s another victory in the fight against cervical cancer – explains Massimo Milione, the director of the Department of Pathological Anatomy 1 – because we are able to monitor and treat women with a higher risk chance, and this has been possible thanks to funding and a collaboration with LILT (Lega Italiana per la Lotta ai Tumori) that gave us the opportunity to access the platform that we use to identify any potential risk.”
This HPV test differs from the simple Pap-test because the new platform, already in operation, is able to offer very accurate and reliable results thanks to a higher detection sensitivity.

I3LUNG: personalized medical care in patients with lung cancer

Designed and presented to implement an innovative, sustainable and high-quality healthcare methodology, I3LUNG is a research initiative in the field of lung cancer that aims to create an innovative decision-making tool that will help both doctors and their patients to select the best therapeutic choice. It will use Artificial Intelligence (AI), in particular the “Deep Learning” and “Machine Learning” methodologies, to analyze a large amount of information. The clinical characteristics, the radiological and molecular images of the tumor of 2,000 patients enrolled in clinical trials in the participating centers will be collected and “multiomic” biological data will be generated, including the mutational load of the tumor, the analysis of the intestinal microbiome, the tumor and circulating immune expression profile, and the metabolomics of 200 patients enrolled in the prospective part of the study.